Nuvation Bio Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nuvation Bio Inc's ROI in the first quarter of 2026?
Nuvation Bio Inc recorded a cumulative net loss of $-146 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -26.84%.

Within the Healthcare sector 361 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 3270 to 3292.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Investment Change TTM	27.75 %	11.05 %	2.53 %	-3.49 %	-30.4 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	549	513	533	581	440
Return On Investment (TTM)	-26.84 %	-39.61 %	-42.72 %	-40.27 %	-142.39 %
NUVB's Overall Ranking	# 3292	# 3270	# 1101	# 3263	# 3221
Seq. Investment Change TTM	5.3 %	1.48 %	1.04 %	18.32 %	-8.47 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-146	-205	-217	-203	-606

NUVB Company Profile >> Back to NUVB Roi Comparisons >> See Annual NUVB Return On Investment

Return On Investment NUVB's Ranking
Within:	No.
Industry	# 133
Sector	# 362
Overall	# 3292

Return On Investment Statistics
High	Average	Low
-10.96 %	-41.74 %	-142.39 %
(Dec 31 2021)		(Mar 31 2025)

Financial Statements
Nuvation Bio Inc's I. Quarter Investments	$ 549 Millions	NUVB's Balance sheet
Nuvation Bio Inc's I. Quarter Income	$ 5 Millions	Quarterly NUVB's Income Statement
NUVB's Income by Division		See NUVB's Income by Division

NUVB Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	513	482	608	659	759
Y / Y Investment Growth	6.26 %	-20.6 %	-7.81 %	-13.2 %	433.89 %
Net Income in Millions	-205	-568	-76	-104	-87
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-39.92 %	-117.74 %	-12.48 %	-15.81 %	-11.44 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NUVB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NUVB's Competitors
Subscribers only: Roi for Nuvation Bio Inc's Suppliers
Subscribers only: Return On Investment for NUVB's Customers

Other Ratios
NUVB's Roa	NUVB's Inventory Turnover Ratio	NUVB's Growth Rates	NUVB's Dividend Statistics
	NUVB's Profitability Ratios	NUVB's Asset Turnover Ratio	NUVB's Dividend Growth
NUVB's Roe	NUVB's Valuation Ratios	NUVB's Financial Strength Ratios	NUVB's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector

ROI

Date modified: 2026-08-30T15:01:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.